Skip to main content
. 2019 Mar 3;8(3):301. doi: 10.3390/jcm8030301

Table 1.

Patient baseline characteristics with regard to TREM-1 rs2234237 genotypes.

All (n = 649) AA/AT (n = 104) TT (n = 545) p-Value
General
Age in years 63 ± 15 64 ± 14 63 ± 15 0.5392
Sex: Male (%) 66 66 66 0.9254
BMI 28 ± 6 27 ± 6 28 ± 6 0.9725
Severity
SOFA Day 1 9.4 ± 3.9 9.0 ± 4.1 9.4 ± 3.8 0.1421
APACHE II Day 1 22 ± 7 21 ± 7 22 ± 7 0.3042
Septic shock (%) 51 57 50 0.1800
Days in septic shock 2 ± 3 2 ± 3 2 ± 3 0.1453
Procalcitonin ng/dl Day 1 10 ± 29 10 ± 26 10 ± 30 0.8157
Comorbidities (%)
Hypertension 54 50 55 0.3804
History of myocardial infarction 5 1 6 0.0290
Chronic obstructive pulmonary disease 15 14 15 0.8703
Bronchial asthma 3 2 3 0.6275
Renal dysfunction 10 11 10 0.9262
Noninsulin-dependent diabetes mellitus 9 11 8 0.4805
Insulin-dependent diabetes mellitus 10 11 10 0.9712
Chronic liver disease 6 5 7 0.4898
History of cancer 15 20 15 0.2387
History of stroke 6 4 6 0.3410
Dementia 3 4 3 0.7800
Rheumatoid arthritis 1 0 1 0.2824
Recent surgical history (%) 0.0103
Elective surgery 29 40 27
Emergency surgery 53 49 54
No surgery 18 11 19
Organ support during observation period (%)
Mechanical ventilation 93 92 94 0.6332
Use of vasopressor 79 78 79 0.7186
Renal replacement therapy 21 18 21 0.5133
Organ support on sepsis onset (%)
Mechanical ventilation 86 87 86 0.8200
Use of vasopressor 67 64 67 0.5878
Renal replacement therapy 9 8 9 0.6681
Length of stay:
LOS ICU 20 ± 16 21 ± 17 20 ± 16 0.7486

Footnote: SOFA, sequential organ failure assessment; APACHE, acute physiology and chronic health evaluation; LOS, Length of stay; ICU, Intensive care unit; BMI, body mass index.